Skip to content

Fast Reversal of Warfarin and Early Surgery in Patients With Trochanteric Hip Fracture A Case-control Study

Is Fast Reversal and Early Surgery (Within 24 h) in Patients on Warfarin Medication With Trochanteric Hip Fractures Safe: A Case-control Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04614090
Enrollment
198
Registered
2020-11-03
Start date
2017-10-01
Completion date
2018-06-26
Last updated
2020-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early Surgery, Trochanteric Hip Fractures, Warfarin Medication

Keywords

Hip fracture, Surgical treatment, Warfarin, Anticoagulation treatment, Intramedullary nailing

Brief summary

A retrospective case-control study. To evaluate if early surgery within 24hours of troch or subtrochanteric hip fractures using intramedullary nailing is safe in patients on warfarin treatment after fast reversal of the warfarin effect

Interventions

None listed

Sponsors

Stockholm South General Hospital
CollaboratorOTHER
Karolinska Institutet
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum

Exclusion criteria

* Pathological fracture * Late presentation to the hospital * Other injuries

Design outcomes

Primary

MeasureTime frameDescription
Transfusion ratesPre-surgeryHb value (g/dl)
adverse eventsImmediately after the surgeryNumber of patients with a myocardial infarction, stroke, pulmonary embolism, deep venous thrombosis, sepsis, pneumonia, urinary tract infection, pressure ulcer, or any adverse events.
mortalityImmediately after the surgeryThe number of deaths

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026